Tandem Diabetes Care, Inc. TNDM Cash Flow

Tandem diabetes care, inc. (TNDM)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13
Operating Activities
Net loss
-16,675	-24,800	-23,717	-55,062	-112,910	-122,611	-137,705	-119,493	-81,934	-73,033	-76,450	-90,231	-86,755	-83,447	-80,714	-70,485	-71,694	-72,418	-78,794	-79,107	-78,770	-79,524	-84,671	-77,833	-73,937	-63,139	0	0	0
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization expense
6,464	6,072	5,898	5,869	5,766	5,821	6,482	6,748	6,931	6,866	6,209	5,787	5,583	5,489	5,236	5,133	4,981	4,829	4,914	4,885	4,650	4,389	3,788	3,378	3,303	3,167	0	0	0
Interest expense related to amortization of debt discount and debt issuance costs
-	-	-	-	-	1,721	2,266	2,453	2,281	1,883	1,418	949	490	274	223	209	181	138	152	156	161	219	610	431	404	595	0	0	0
Payment in kind interest accrual of notes payable
-	-	-	-	-	-	-	-	-	1,657	1,488	1,304	1,120	927	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Provision for Doubtful Accounts
2,842	2,322	1,899	1,500	1,431	1,448	1,177	1,152	876	824	630	448	567	632	744	771	473	70	75	-13	103	188	235	280	284	275	0	0	0
Provision (benefit) for inventory obsolescence
1,311	2,353	1,718	1,441	1,179	607	107	-55	2	26	0	0	0	-	-	-	-	-	-	-	-	163	542	875	1,051	815	0	0	0
Change in fair value of common stock warrants
251	11,075	8,301	22,887	65,012	66,494	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	9,002	0	0	0
Amortization of discount on short-term investments
537	565	546	-75	-386	-539	-783	-298	-56	16	42	82	115	85	34	-22	-39	-4	41	69	65	53	0	0	0	-	-	-	-
Stock-based compensation expense
64,102	58,071	49,695	42,002	32,378	23,736	15,553	8,408	10,856	12,628	13,429	13,942	11,824	11,660	11,819	11,891	12,123	13,096	13,957	14,726	14,997	14,995	13,894	11,113	8,170	4,456	0	0	0
Other
-329	-321	39	27	31	152	245	244	243	159	28	93	21	-78	-119	-104	-51	-76	0	0	0	-	-	-	-	-	-	-	-
Changes in operating assets and liabilities:
Restricted cash
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Accounts receivable, net
23,811	13,698	25,523	35,971	21,684	15,848	12,285	6,036	5,966	10,445	3,013	51	-839	-2,251	1,935	2,724	4,340	6,473	1,239	3,097	1,905	2,541	1,910	1,909	1,491	3,161	0	0	0
Inventories, net
38,380	30,975	17,986	3,656	-2,724	-6,756	-5,896	-861	2,937	5,894	8,832	7,593	6,897	6,904	7,207	7,300	7,048	6,084	6,035	3,704	3,290	1,820	1,545	2,002	2,306	4,625	0	0	0
Prepaid and other current assets
1,779	584	770	3,288	1,867	1,576	125	524	-1,554	-1,831	-75	-233	2,362	2,466	1,093	1,311	911	395	1,184	-473	20	82	314	806	817	-106	0	0	0
Other long-term assets
738	580	374	398	233	26	-18	19	-29	-4	47	7	43	2	5	-133	-146	-131	0	0	0	-	-	-	-	-	-	-	-
Accounts payable
8,828	8,910	7,689	5,580	7,671	1,641	-1,392	-3,239	-882	-1,953	3,465	1,056	-511	3,234	1,422	3,698	3,021	3,355	383	86	610	-1,225	1,632	1,091	1,271	859	0	0	0
Accrued expenses
2,505	4,076	4,044	1,502	178	1,097	1,394	3,522	714	1,203	554	-1,448	322	-497	-618	277	-438	-734	1,396	227	1,098	973	-1,190	105	83	342	0	0	0
Employee-related liabilities
5,014	4,285	10,974	10,250	6,538	9,542	5,817	519	-1,552	3,873	444	1,737	2,092	-1,578	682	2,275	749	2,039	1,486	3,179	2,214	3,846	3,646	1,556	3,515	3,885	0	0	0
Deferred revenue
5,252	4,589	4,483	4,174	2,586	2,074	1,409	-2,117	-2,134	-3,906	-8,055	3,318	3,328	4,610	8,398	725	877	981	1,313	524	421	429	467	410	343	-1,472	0	0	0
Other current liabilities
6,767	4,216	3,669	1,433	670	2,434	1,269	369	-406	-432	-1,376	-680	330	573	3,077	2,374	1,945	1,924	442	-381	-459	-1,575	-2,242	-685	-2,864	895	0	0	0
Deferred rent
-	-	-	-	-	-	0	0	-715	-	142	188	49	1	-728	-776	-690	-631	-619	-608	-545	-461	-401	-394	-447	-522	0	0	0
Other long-term liabilities
4,264	7,412	6,532	5,749	3,446	2,367	1,389	752	237	-390	2	216	604	890	295	289	581	923	1,247	1,513	1,243	810	843	485	1,029	763	0	0	0
Net cash used in operating activities
25,398	41,905	36,596	10,120	-171	-8,319	-34,093	-49,654	-57,596	-66,136	-68,077	-67,213	-66,040	-61,173	-57,837	-54,021	-59,287	-58,764	-62,055	-61,298	-59,840	-61,378	-60,667	-58,041	-55,906	-47,757	0	0	0
Investing Activities
Purchases of short-term investments
131,385	164,572	149,310	157,217	157,467	123,553	0	0	0	-	-	-	-	30,622	38,610	43,855	54,533	80,191	72,716	90,265	77,367	67,101	0	0	0	-	-	-	-
Proceeds from maturities of short-term investments
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from sales of short-term investments
0	-	-	-	0	-	-	-	-	0	20,550	31,750	41,500	50,000	61,200	71,750	80,700	88,450	0	0	0	-	-	-	-	-	-	-	-
Purchases of property and equipment
24,899	19,541	13,680	10,068	3,880	2,986	3,517	2,750	3,589	5,718	7,042	8,937	9,628	8,930	7,857	7,461	7,109	5,764	4,840	4,067	3,386	4,406	5,139	5,283	4,728	4,010	0	0	0
Purchase of patents
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	74	74	74	74	173	173	1,673	1,673	2,000	0	0	0
Net cash provided by investing activities
-24,817	-56,955	-42,645	-67,285	-80,447	-90,739	-85,567	-39,000	-9,339	2,782	8,776	14,848	14,691	10,448	14,733	20,434	19,058	2,421	1,070	-25,606	-23,117	-35,470	-49,553	-37,020	-40,329	-11,105	0	0	0
Financing Activities
Proceeds from exercise of common stock warrants
270	327	366	737	23,127	29,575	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of notes payable, net of issuance costs
-	-	-	-	-	-	-	-	-	-	-	-	-	49,994	0	0	0	-	-	-	-	-	-	-	-	28,874	0	0	0
Restricted cash in connection with notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,000	0	0	0
Principal payments on notes payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	4,396	0	0	0
Proceeds from issuance of preferred stock for cash, net of offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Proceeds from public offerings, net of offering costs
-	-	-	-	-	172,929	187,610	82,679	82,368	39,806	0	0	0	-	-	-	-	64,862	0	0	0	-	-	-	-	-	-	-	-
Proceeds from issuance of common stock under Company stock plans
33,456	23,880	0	0	0	-	-	-	-	-	-	-	2,478	2,321	2,861	2,922	3,285	3,393	0	0	0	-	-	-	-	2,575	0	0	0
Net cash provided by financing activities
33,726	24,207	19,746	34,759	48,477	117,184	129,908	111,851	89,184	40,376	61,424	57,466	59,073	52,315	17,855	17,916	18,290	68,255	68,632	68,617	68,680	3,639	130,228	129,137	143,624	166,084	0	0	0
Effect of foreign exchange rate changes on cash
-268	191	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
34,039	9,348	13,733	-22,391	-32,138	18,126	10,248	23,197	22,249	-22,978	2,123	5,101	7,724	1,590	-25,249	-15,671	-21,939	11,912	7,647	-18,287	-14,277	-93,209	20,007	34,075	47,388	107,222	0	0	0
Supplemental disclosures of cash flow information
Interest paid
-	-	-	-	-	10,805	7,846	8,778	8,329	7,876	7,067	6,184	5,318	4,401	3,934	3,709	3,491	3,345	3,185	3,185	3,182	3,369	3,248	3,472	4,040	4,115	0	0	0
Income taxes paid
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	0
Supplemental schedule of non-cash investing and financing activities
Right-of-use assets obtained in exchange for operating lease obligations
17,387	11,635	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease incentive - lessor-paid tenant improvements
-	-	-	-	-	-	-	-	-	3,292	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Debt discount included in other long-term liabilities
-	-	-	-	-	-	-	5,006	2,405	4,137	7,775	5,150	3,616	1,509	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Common stock warrants issued in connection with term loan
-	-	-	-	-	-	-	-	-	3,331	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Public offering costs included in accounts payable
-	-	-	-	-	-	-	-	0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Property and equipment included in accounts payable
3,884	2,134	2,552	272	38	125	77	124	80	92	-229	-34	289	501	1,625	542	260	1,457	1,377	2,240	2,278	789	0	0	0	-	0	0	0
Common warrants issued
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0